MPCi & Centurium Joins Lilly Asia in Cancer Treatment
20 Mar 2026
US$ 20.00
MPCi and Centurium Capital have co-led a US$27.7 m seed extension round for Excalipoint Therapeutics Inc ......
Related Publications
Subscribers’ Weekly for the week ending 20 Mar 2026...
Listen to China Investments (Subscribers' Weekly 20 Mar 2026)...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.